Implicit Bioscience
Brian Ziegelaar, PhD, currently serves as Vice President of Operations at Implicit Bioscience, where responsibilities include leadership in ophthalmology, cardiology, and neurotrauma indications, as well as repurposing biologic and small molecule drugs for various medical conditions. Prior experience includes roles as Operations Manager and International Product Manager at Tissue Therapies Limited, focusing on advanced wound care market strategies and product launches. Additionally, Brian contributed to sales and technical support as European Sales and International Product Manager at ImpediMed Limited. Educational background includes a PhD in Tissue Engineering of Cartilage from Ludwig-Maximilians-Universität München, a Master's in Medical Science from The University of Western Australia, and a Bachelor's in Applied Science from the same institution.
This person is not in any offices
Implicit Bioscience
Implicit Bioscience operates as a clinical-stage drug development company. It applies breakthrough discoveries in immunology to make transformational changes to the way they manage inflammatory and infectious diseases.Implicit Bioscience was founded in 2004 and is based in Seattle, Washington.